A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe when added to treatment with lithium or Divalproex for the treatment of patients with bipolar I depression.
Inclusion Criteria:
Exclusion Criteria:
Garden Grove, California 92645, United States
Albuquerque, New Mexico 87109, United States
Raleigh, North Carolina 27609, United States
Austin, Texas 78756, United States
Brno - Mesto, 602 00, Czechia
Berlin BE, 10245, Germany
Vijaywada, Andh Prad 520002, India
Delhi, National Capital Territory of Delhi 110092, India
Vinnitsia, 21005, Ukraine